A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-Specific Wnt4 Activation and Repression
Abdelkader Essafi(Western General Hospital), Peter Hohenstein(Roslin Institute), Stefan G. E. Roberts(University of Bristol), Víctor Velecela(Western General Hospital), Ofelia M. Martínez-Estrada(Western General Hospital), Lee Spraggon(Western General Hospital), John H. Wiltshire(Western General Hospital), Sally F. Burn(Western General Hospital), David G. Brownstein(The Queen's Medical Research Institute), Anna Webb(Western General Hospital), Jamie A. Davies(University of Edinburgh), Joan Slight(Western General Hospital), N D Hastie(Western General Hospital), Rachel L. Berry(Western General Hospital)
Cited by 163
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
|Nucleic Acids Research|2015|1k
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
|Nature Genetics|2008|806
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712